BIO Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own BIO shares is 652, representing 87.73% of the company's common stock.

SWISS NATIONAL BANK, in the last quarter, reduced its stake in BIO by -3.99% restricting it's holding to 64.9 thousand shares of worth nearly $22.45M. CANDRIAM S.C.A. also lessened -39.94% of the BIO shares from its portfolio, reducing its holding to 59.66 thousand shares of worth $20.63M. SUMITOMO MITSUI TRUST HOLDINGS, INC. also shunned BIO shares holding by -1.95% last quarter which brought its holding to 50.56 thousand shares worth $17.49M.

As per its latest 13F filing, ARIEL INVESTMENTS, LLC increased its stake in BIO by 1,353.92% in the last quarter. The institutional holder raised its holding to 65.09 thousand shares having worth more than $22.51M. SUSQUEHANNA INTERNATIONAL GROUP, LLP also added 100% more shares of BIO to its portfolio, raising its holding to 58.7 thousand shares of worth $20.30M. UBS GROUP AG also increased its BIO shares holding by 50.16% which brought its holding to 53.3 thousand shares worth $18.44M.

The insider with the most stakes in BIO is GOETZ JOHN , EVP, Chief Operating Officer at the company. Additionally, BIO stock is highly held by EVP, Chief Strategy Officer Magni Giovanni and Executive Vice President HERTIA JOHN among others.

Company executives, directors, and other insiders own 15.57% percent of Bio-Rad Laboratories, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which BIO insiders have sold stock, totaling 0 shares. Insiders that have sold shares include WRIGHT DARA, CROWLEY MICHAEL, and ERNST TIMOTHY S.

There have been 0 transaction(s) during the past 6-months in which Bio-Rad Laboratories, Inc. insiders have bought stock, totalling 0 shares

Around 0 Bio-Rad Laboratories, Inc. shares are held by insiders, which represents about 15.57% of BIO stock.

BIO EVP, Chief Operating Officer, GOETZ JOHN holds the largest portfolio of the company's shares. BIO shares owned by GOETZ total nearly 61.17 thousand.

ARIEL INVESTMENTS, LLC is the largest institutional owner in BIO which holds 65.09 thousand shares worth $22.51M or 0.23% of the total BIO shares outstanding followed by SWISS NATIONAL BANK with ownership of 64.9 thousand shares representing 0.23% of the BIO ownership. CANDRIAM S.C.A. is the third largest stakeholder with 59.66 thousand shares or 0.21% of the ownership worth more than $20.63M.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the BIO is concerned, it is a stock which is optionable.

Number of BIO shares short is 655.52K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 22.92M shares of BIO are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, BIO has 19.44M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for BIO is 3.72.